Live Breaking News & Updates on Car Therapy Development

Stay updated with breaking news from Car therapy development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Worldwide CAR T-Cell Therapy Industry to 2030 - Players Include Legend Biotech, Novartis & Pfizer Among Others


Share this article
Share this article
ResearchAndMarkets.com s offering.
The scientific community has been pursuing research for the development of CAR T-cell therapy for over a century. Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patient s immune system to attack cancer. The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030. The market is driven by certain factors, which include increasing global geriatric population, increasing number of lymphoma and leukemia cases, rising number of relapsed or refractory cancer cases showing response failure to alternative treatments such as chemotherapy and radiation therapy, focus on research and development of novel immunotherapies, and strong product pipeline of global CAR T-cell therapy. ....

United States , South Korea , Brexucabtagene Autoleucel Tecartus , Axicabtagene Ciloleucel , Tisagenlecleucel Kymriah , Idecaptagene Cicleucel , Lisocabtagene Maraleucel , Laura Wood , Axicabtagene Ciloleucel Yescarta , Kite Pharma Inca Gilead Company , Janssen Pharmaceuticals Inc , Research Scope , Bristol Myers Squibb Company , Pfizer Inc , Legend Biotech Corporation , Technology Definition , Bluebird Bio Inc , Car Therapy Development , Bellicum Pharmaceuticals Inc , Kite Pharma Inc , Custom Research , Company Overview , Carsgen Therapeutics Ltd , Office Hours Call , Cartesian Therapeutics Inc , Research Methodology ,